HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jin Wang Selected Research

Polyynes

1/2019Synergetic Inhibition of Human Colorectal Cancer Cells by Combining Polyyne-Enriched Fraction from Oplopanax elatus and Irinotecan.
1/2019Chemo-Preventive Potential of Falcarindiol-Enriched Fraction from Oplopanax elatus on Colorectal Cancer Interfered by Human Gut Microbiota.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jin Wang Research Topics

Disease

401Neoplasms (Cancer)
09/2022 - 03/2003
86Infections
06/2022 - 12/2002
69Neoplasm Metastasis (Metastasis)
07/2022 - 08/2004
64Inflammation (Inflammations)
11/2022 - 10/2005
50Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022 - 01/2006
43Breast Neoplasms (Breast Cancer)
08/2022 - 03/2003
41Stomach Neoplasms (Stomach Cancer)
01/2022 - 02/2004
38Hepatocellular Carcinoma (Hepatoma)
07/2022 - 09/2009
37Osteosarcoma (Osteogenic Sarcoma)
01/2022 - 09/2006
33Wounds and Injuries (Trauma)
03/2022 - 10/2006
32Lung Neoplasms (Lung Cancer)
04/2022 - 12/2003
31Fibrosis (Cirrhosis)
06/2022 - 11/2009
31Hypoxia (Hypoxemia)
06/2022 - 05/2005
30Carcinogenesis
01/2022 - 11/2003
28Alzheimer Disease (Alzheimer's Disease)
06/2022 - 08/2002
28Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 10/2008
26Carcinoma (Carcinomatosis)
03/2022 - 02/2004
25Thrombosis (Thrombus)
05/2022 - 10/2007
23Hypertension (High Blood Pressure)
03/2022 - 01/2005
22Myocardial Infarction
08/2021 - 12/2010
20Leukemia
01/2022 - 01/2004
19COVID-19
09/2022 - 01/2020
19Pancreatic Neoplasms (Pancreatic Cancer)
07/2022 - 09/2009
18Reperfusion Injury
12/2022 - 09/2005
18Ischemia
08/2022 - 08/2004
18Body Weight (Weight, Body)
01/2021 - 01/2009
17Pain (Aches)
07/2022 - 06/2005
17Cognitive Dysfunction
01/2022 - 09/2014
16Hemorrhage
05/2022 - 01/2015
14Cardiovascular Diseases (Cardiovascular Disease)
11/2022 - 06/2010
14Triple Negative Breast Neoplasms
01/2021 - 12/2013
13Adenocarcinoma
03/2022 - 08/2004
13Prostatic Neoplasms (Prostate Cancer)
01/2022 - 02/2007
12Colitis
07/2022 - 11/2011
12Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 01/2010
12Traumatic Brain Injuries (Traumatic Brain Injury)
01/2022 - 08/2011
12Lymphatic Metastasis
09/2021 - 06/2012
12Melanoma (Melanoma, Malignant)
10/2020 - 03/2012
11Neuroinflammatory Diseases
11/2022 - 01/2016
11Alopecia (Baldness)
10/2022 - 09/2019
11Brain Ischemia (Cerebral Ischemia)
08/2022 - 09/2005
11Insulin Resistance
04/2022 - 07/2004
11Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
01/2022 - 10/2007
11Virus Diseases (Viral Diseases)
01/2022 - 02/2006
11Stroke (Strokes)
01/2022 - 05/2012
11Tuberculosis (Tuberculoses)
11/2021 - 11/2007
11Hyperlipidemias (Hyperlipidemia)
06/2021 - 10/2009
10Diabetic Nephropathies (Diabetic Nephropathy)
10/2022 - 03/2012
9Myocardial Ischemia (Ischemic Heart Diseases)
12/2022 - 08/2004
9Atherosclerosis
11/2022 - 09/2015
9Ischemic Stroke
08/2022 - 07/2009

Drug/Important Bio-Agent (IBA)

133Proteins (Proteins, Gene)FDA Link
11/2022 - 01/2004
92Biomarkers (Surrogate Marker)IBA
07/2022 - 03/2007
72Pharmaceutical PreparationsIBA
09/2022 - 10/2005
65MicroRNAs (MicroRNA)IBA
12/2022 - 10/2008
52Biological ProductsIBA
02/2022 - 09/2007
48Messenger RNA (mRNA)IBA
09/2022 - 12/2004
27LipidsIBA
01/2022 - 01/2009
26RNA (Ribonucleic Acid)IBA
09/2022 - 08/2007
25Glucose (Dextrose)FDA LinkGeneric
04/2022 - 04/2009
24DNA (Deoxyribonucleic Acid)IBA
02/2022 - 09/2004
23CytokinesIBA
07/2022 - 10/2005
22VaccinesIBA
01/2022 - 12/2002
21EnzymesIBA
01/2022 - 03/2005
20Peptides (Polypeptides)IBA
06/2022 - 06/2003
19Long Noncoding RNAIBA
01/2022 - 01/2016
18Circular RNAIBA
01/2022 - 01/2018
16CateninsIBA
01/2022 - 12/2011
15Interleukin-6 (Interleukin 6)IBA
11/2022 - 01/2005
15LigandsIBA
01/2022 - 11/2008
15Therapeutic UsesIBA
01/2022 - 01/2012
15AntigensIBA
01/2022 - 12/2002
15Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 02/2005
14Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2022 - 05/2005
14Small Interfering RNA (siRNA)IBA
02/2022 - 01/2007
14Indicators and Reagents (Reagents)IBA
01/2022 - 11/2004
14Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 01/2008
12InflammasomesIBA
10/2022 - 05/2019
12Caspase 3 (Caspase-3)IBA
06/2022 - 01/2013
12Adenosine Triphosphate (ATP)IBA
03/2022 - 06/2010
12Reactive Oxygen Species (Oxygen Radicals)IBA
03/2022 - 01/2013
12Amyloid (Amyloid Fibrils)IBA
01/2022 - 07/2015
12Oxygen (Dioxygen)IBA
11/2021 - 05/2008
12CholesterolIBA
04/2021 - 09/2006
11Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2022 - 01/2005
11ErbB Receptors (EGF Receptor)IBA
01/2021 - 02/2007
11AntioxidantsIBA
03/2020 - 09/2005
10AntibodiesIBA
05/2022 - 06/2003
10Capsules (Microcapsules)IBA
01/2022 - 09/2007
10Phosphotransferases (Kinase)IBA
01/2022 - 02/2010
10AutoantibodiesIBA
05/2021 - 02/2006
9LipopolysaccharidesIBA
09/2022 - 08/2004

Therapy/Procedure

165Therapeutics
08/2022 - 02/2005
73Drug Therapy (Chemotherapy)
10/2022 - 01/2006
48Radiotherapy
05/2022 - 12/2003
22Immunotherapy
02/2022 - 11/2006
21Stents
08/2021 - 06/2010
14Transplantation
01/2022 - 04/2008
11Aftercare (After-Treatment)
06/2022 - 08/2009
10Chemoradiotherapy
10/2021 - 06/2010